Huang X, Weng L, Yi L, Li M, Feng Y Y, Tian Y, Xia J G, Zhan Q Y, Du B
Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Zhonghua Yi Xue Za Zhi. 2016 Oct 18;96(38):3057-3061. doi: 10.3760/cma.j.issn.0376-2491.2016.38.005.
To examine the clinical features of patients with acute respiratory failure (ARF) caused by pneumocystis pneumonia (PCP) admitted into two medical intensive care units (ICU) in non- human immunodeficiency virus (HIV) infected immunocompromised patients. A retrospective review was conducted among 92 non-HIV patients with ARF caused by PCP in medical ICU of Peking Union Medical College Hospital and China-Japan Friendship Hospital between Jan 2010 and Dec 2015. Patient characteristics, clinical presentation, laboratory and radiological findings, complications, as well as therapy and mortality were included in the analysis. All patients were immunocompromised before PCP, among which 69.6% (64/92) patients were suffered from autoimmune disease. The diagnosis of PCP was made by the identification of P. jiroveci organisms with Giemsa or polymerase chain reaction in specimens of bronchoalveolar lavage, sputum or tracheal aspiration. The Acute Physiology and Chronic Health Evaluation (APACHE) Ⅱ was high (19±5) and the partial pressure of oxygen/ fraction of inspiration oxygen(PaO/FiO) ratio was low[(139.6±65.4) mmHg]on ICU admission, with all patients diagnosed as acute respiratory failure during ICU stay. Radiologic findings showed bilateral diffused ground glass opacity (94.6%, 87/92). All patients received Compound Sulfamethoxazole (SMZ/TMP) and only 3.3% (3/92) patients were not given conjunctive corticosteroid. 57.6% (53/92) and 21.7% (20/92) patients were coinfected by cytomegalovirus (CMV) and aspergillos. Invasive ventilatory support was required in 90% (81/90) patients. 22% (18/82) patients used non-invasive positive pressure ventilation (NPPV) on ICU admission but most of them (83.3%, 15/18) failed and switched to invasive positive pressure ventilation (IPPV). Median ICU and hospital length of stay were 11 and 17 days, respectively. The overall hospital mortality rate was 76.1% (70/92). Among patients with ARF secondary to non-HIV related PCP, autoimmune system diseases are the most common primary diagnosis. The clinical manifestations were severe and coinfections are common, with poor prognosis.
为研究非人类免疫缺陷病毒(HIV)感染的免疫功能低下患者因肺孢子菌肺炎(PCP)导致急性呼吸衰竭(ARF)并入住两个医学重症监护病房(ICU)患者的临床特征。对2010年1月至2015年12月期间在北京协和医院和中日友好医院医学ICU中92例非HIV感染的因PCP导致ARF的患者进行了回顾性研究。分析内容包括患者特征、临床表现、实验室及影像学检查结果、并发症以及治疗和死亡率。所有患者在发生PCP之前均免疫功能低下,其中69.6%(64/92)的患者患有自身免疫性疾病。通过在支气管肺泡灌洗、痰液或气管吸出物标本中用吉姆萨染色或聚合酶链反应鉴定耶氏肺孢子菌来诊断PCP。入住ICU时急性生理与慢性健康状况评分系统(APACHE)Ⅱ评分较高(19±5),氧分压/吸入氧分数(PaO/FiO)比值较低[(139.6±65.4)mmHg],所有患者在ICU住院期间均被诊断为急性呼吸衰竭。影像学检查结果显示双侧弥漫性磨玻璃影(94.6%,87/92)。所有患者均接受复方磺胺甲恶唑(SMZ/TMP)治疗,仅3.3%(3/92)的患者未给予联合使用的糖皮质激素。57.6%(53/92)和21.7%(20/92)的患者合并巨细胞病毒(CMV)和曲霉感染。90%(81/90)的患者需要有创通气支持。22%(18/82)的患者在入住ICU时使用无创正压通气(NPPV),但其中大多数(83.3%,15/18)失败并转为有创正压通气(IPPV)。ICU中位住院时间和医院中位住院时间分别为11天和17天。医院总体死亡率为76.1%(70/92)。在非HIV相关PCP继发ARF的患者中,自身免疫系统疾病是最常见的初始诊断。临床表现严重,合并感染常见,预后较差。